Premium
Immunoglobulin allotypes in patients with squamous cell carcinoma of the head and neck
Author(s) -
Ockhuizen Theodorus,
Pandey Janardan P.,
Veltri Robert W.,
Arlen Myron,
Hugh Fudenberg H.
Publication year - 1982
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19820515)49:10<2021::aid-cncr2820491013>3.0.co;2-b
Subject(s) - medicine , head and neck , antibody , head and neck cancer , basal cell , head and neck squamous cell carcinoma , population , squamous cell cancer , carcinoma , epidermoid carcinoma , cancer , pathology , immunology , surgery , environmental health
Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(I) allotypic marker, and antibodies against IgA1, A2m(I), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significantly increased in patients with head and neck cancer as compared to the control population.